Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Rawls

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Drug and Alcohol Dependence|January 20, 2022
The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbensHelene L Philogene-Khalid, Mary F Morrison, Nune Darbinian, et al.
Neuroscience Letters|May 31, 2008
Withdrawal-like behavior in planarians is dependent on drug exposure durationSteve Sacavage, Hiren Patel, Mike Zielinski, et al.
Brain, Behavior, and Immunity|January 10, 2024
Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in ratsSaadet Inan, Joseph J Meissler, Shingo Bessho, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2009
Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide productionJennifer Werkheiser, Alan Cowan, Teresa Gomez, et al.
Neuroscience and Biobehavioral Reviews|April 1, 2017
Factors affecting increased risk for substance use disorders following traumatic brain injury: What we can learn from animal modelsSteven F Merkel, Lee Anne Cannella, Roshanak Razmpour, et al.
Drug and Alcohol Dependence|March 8, 2020
Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanismJeffery D Foss, Sunil U Nayak, Christopher S Tallarida, et al.
Journal of Neuroscience Methods|October 19, 2017
PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effectsAshenafi Mebratu Zewde, Frances Yu, Sunil Nayak, et al.
Cannabis and Cannabinoid Research|July 19, 2023
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in TherapyDaniel J Farkas, Ziva D Cooper, Laila N Heydari, et al.
Drug and Alcohol Dependence|March 19, 2018
Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in ratsChicora F Oliver, Steven J Simmons, Sunil U Nayak, et al.
Behavioural Pharmacology|May 26, 2026
Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsRazeen J Akbar, Amy D Stringer, Sonita Wiah, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Drug and Alcohol Dependence|January 20, 2022
The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbensHelene L Philogene-Khalid, Mary F Morrison, Nune Darbinian, et al.
Neuroscience Letters|May 31, 2008
Withdrawal-like behavior in planarians is dependent on drug exposure durationSteve Sacavage, Hiren Patel, Mike Zielinski, et al.
Brain, Behavior, and Immunity|January 10, 2024
Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in ratsSaadet Inan, Joseph J Meissler, Shingo Bessho, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2009
Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide productionJennifer Werkheiser, Alan Cowan, Teresa Gomez, et al.
Neuroscience and Biobehavioral Reviews|April 1, 2017
Factors affecting increased risk for substance use disorders following traumatic brain injury: What we can learn from animal modelsSteven F Merkel, Lee Anne Cannella, Roshanak Razmpour, et al.
Drug and Alcohol Dependence|March 8, 2020
Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanismJeffery D Foss, Sunil U Nayak, Christopher S Tallarida, et al.
Journal of Neuroscience Methods|October 19, 2017
PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effectsAshenafi Mebratu Zewde, Frances Yu, Sunil Nayak, et al.
Cannabis and Cannabinoid Research|July 19, 2023
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in TherapyDaniel J Farkas, Ziva D Cooper, Laila N Heydari, et al.
Drug and Alcohol Dependence|March 19, 2018
Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in ratsChicora F Oliver, Steven J Simmons, Sunil U Nayak, et al.
Behavioural Pharmacology|May 26, 2026
Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsRazeen J Akbar, Amy D Stringer, Sonita Wiah, et al.
Pageof 14